The annual Innovative Technology Exchange is part of Vizient's Innovative Technology Program that includes a product review of supplier-submitted technologies by member-led councils and task forces.
The annual Innovative Technology Exchange is part of Vizient's Innovative Technology Program that includes a product review of supplier-submitted technologies by member-led councils and task forces.
The integration provides the opportunity for monitoring during image-guided procedures on the Philips Image Guided Therapy System – Azurion, improving workflow with comprehensive patient records that support timely clinical decision-making during interventional cardiology procedures and beyond.
Today, more than 1,600 clinical cases using the Olympus EBUS solution prove that EBUS-TBNA (transbronchial needle aspiration) is an effective biopsy solution, providing higher diagnostic yield with greater sensitivity and specificity in lymph nodes ≥5 mm.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today celebrated 130 years of innovation, collaboration, and social responsibility. During its rich history since being founded on May 15, 1891, in Eindhoven in the Netherlands, the company has continuously reinvented itself to remain relevant to society.
Today, Royal Philips is a leading health technology company with a purpose to improve the lives of 2.5 billion people a year by 2030 through meaningful innovation.
“The company’s 130th anniversary...
The introduction of the H-SteriScope portfolio has been a collaboration between Veran Medical Technologies, Inc., a wholly-owned Olympus subsidiary, and Hunan Vathin Medical Instrument Co., Ltd.
The goal of the collaboration is to drive significant performance improvements in integrated cardiovascular care in terms of the patient and care provider experience, clinical outcomes, and productivity.
This follows the securing of its CE mark certification alongside its FDA CLIA-waiver, meaning that the portable, dual-purpose analyzer is ideal for professional use in the management of diabetes patients.
Philips’ industry leading ultrasound image quality combined with DiA’s AI library of automated solutions will help increase diagnostic confidence, operational efficiency, and access to care for Point-of-Care customers in and out of the hospital.
The high-throughput solution enables clinical and public health laboratories to efficiently test up to 8,000 COVID-19 samples a day with fewer staffing requirements and a reliable supply of kits, reagents and consumables.
"Through this collaboration with the SAZ, our connected care solutions can be scaled up more easily within the Netherlands’ regional hospitals. Our goal is to improve care by using technology to relieve the burden on patients and caregivers," said Léon Kempeneers General Manager Health Systems Philips Benelux
By using this website you agree to accept Medical Device News Magazine Privacy Policy
